In a recent briefing with Austin-based metal nanoparticle developer NovaCentrix (see the November 12, 2007 LRNJ), we noted that its approach to curing nanoparticle inks might not prove defensible. During...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)